In 2011, more than 30,000 transplants took place in the European Union (EU) alone.1
Astellas is a global leader in transplantation, providing immunosuppressant treatments for solid organ transplants such as kidney, liver and heart. Astellas will continue playing a key role in the care of transplant patients.